3 results
DEFA14A
EX-2.1
MRTX
Mirati Therapeutics Inc
10 Oct 23
Additional proxy soliciting materials
7:35am
8-K
EX-2.1
MRTX
Mirati Therapeutics Inc
10 Oct 23
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio with Acquisition of Mirati Therapeutics
7:33am
10-12B/A
EX-2.1
MRTX
Mirati Therapeutics Inc
14 Jun 13
Registration of securities (amended)
12:00am
- Prev
- 1
- Next